CBT
ABMD

Central Bank & Trust’s Abiomed Inc ABMD Stock Holding History

Central Bank & Trust’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-7,427
Closed -$1.32M – 291
2019
Q3 		$1.32M Buy
7,427
+1,093
+17% +$236K 0.28% 78
2019
Q2 		$1.65M Buy
6,334
+5,323
+527% +$1.41M 0.37% 69
2019
Q1 		$289K Buy
1,011
+774
+327% +$257K 0.06% 129
2018
Q4 		$77K Sell
237
-1,368
-85% -$475K 0.02% 155
2018
Q3 		$722K Buy
+1,605
New +$633K 0.17% 90

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Central Bank & Trust's ABMD Position: Q4 2019 in Review

Central Bank & Trust sold out of Abiomed Inc (ABMD) in Q4 2019, closing a stake of 7,427 shares — an estimated $1.32M sold.

Central Bank & Trust first reported a position in ABMD in Q3 2018 and held it in 5 quarters. The position peaked at $1.65M in Q2 2019. 465 funds tracked by Wall St. Rank hold ABMD as of Q4 2019.

  • Central Bank & Trust reported no remaining Abiomed Inc position as of Q4 2019 after selling out during the quarter.
  • Central Bank & Trust sold 7,427 Abiomed Inc shares in Q4 2019, an estimated $1.32M.
  • Central Bank & Trust first reported a position in Abiomed Inc in Q3 2018 and held it in 5 quarters.
  • Central Bank & Trust's Abiomed Inc position peaked at $1.65M in Q2 2019.
  • 465 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2019.

Based on Central Bank & Trust's 13F filing for Q4 2019, filed 13 Jan 2020.